Prime Medicine, Inc. (PRME) Stock Ticker
PRME right now
Market factors today
Unlock the full PRME picture
About Prime Medicine, Inc.
Prime Medicine, Inc. operates as a biotechnology firm, dedicated to delivering genetic therapies for various diseases by strategically employing advanced gene editing technology. Central to their platform is the "Prime Editor" system, which combines a unique Prime Editor protein—a hybrid composed of a Cas protein and a reverse transcriptase enzyme—with a specialized pegRNA molecule. This pegRNA plays a crucial role by both guiding the Prime Editor to a precise location within the genome and providing the essential template for introducing the desired modification to the target DNA sequence. The company, founded in 2019, maintains its headquarters in Cambridge, Massachusetts.
PRME stock facts
| Ticker symbol | PRME |
| Exchange | NASDAQ Global Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $523.8M |
| CEO | Allan Reine |
| Employees | 146 |
| Headquarters | Cambridge, MA, US |
| IPO date | 2022-10-20 |
| Website | www.primemedicine.com |
What you can see for PRME on Tickr
Live PRME price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the PRME report.
Rankings
FAQ
What is the ticker symbol for Prime Medicine, Inc.?
The ticker symbol for Prime Medicine, Inc. is PRME, listed on the NASDAQ Global Market.
What is PRME?
Prime Medicine, Inc. operates as a biotechnology firm, dedicated to delivering genetic therapies for various diseases by strategically employing advanced gene editing technology. Central to their platform is the "Prime Editor" system, which combines a unique Prime Editor protein—a hybrid composed of a Cas protein and a reverse transcriptase enzyme—with a specialized pegRNA molecule. This pegRNA…